In summary, we have identified a relevant role of agrin and perlecan in oral cancer cell adhesion, migration and cisplatin cell resistance, opening new perspectives for further investigations and targeting innovative and/or complementary therapeutic strategies. The gene discussed is AGRN; the disease is lip and oral cavity carcinoma.